ASH 2012: Dr. John M. Pagel Part 1 Game changing medications including ABT-199, Ibrutinib, and GS-1101 for CLL
In the first of three segments of my interview with Dr. John Pagel, he says some amazing things.
"this year from last year in CLL, it's game changing, it's night and day difference from where we're going and where we've come and what this field is evolving to, ...... evolving away from cytotoxic chemotherapy"
"this is an amazing wonderful time"
But enough of me quoting the scientist.
I will let the good doctor introduce himself and share some details about his personal experience and excitement concerning ABT199, ibrubinib, and GS1101.
As I attended more of the ASH science and education sessions, and as I interviewed more of the CLL champions, a more mature full screen story develops about the changes that are coming to the world of treatment.
Even a vegan can say that this isn't a case of too much sizzle, not enough steak. These changes are mighty and meaty.
This is really happening and it's happening fast.
In an upcoming post, I will outline some possible tactics for those of us whose urgent present need for treatment doesn't allow the luxury of waiting for the day in the not too distant future when we can go to our local pharmacy and pick up our bottle of pills to control our cancer along with our toothpaste and shampoo.
But first more, we have much more to learn from Dr. Pagel.